These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6223421)

  • 1. The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival.
    Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
    Transplantation; 1983 Jul; 36(1):50-4. PubMed ID: 6223421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.
    Kerman RH; Kimball PM; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1991 Feb; 51(2):338-42. PubMed ID: 1825242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HLA A, B, and DR blood transfusions and immune responder status on cardiac allograft recipients treated with cyclosporine.
    Kerman RH; van Buren CT; Lewis RM; Frazier OH; Cooley D; Kahan BD
    Transplantation; 1988 Feb; 45(2):333-7. PubMed ID: 3278425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
    Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
    Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved allograft survival of strong immune responder-high risk recipients with adjuvant antithymocyte globulin therapy.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplantation; 1980 Dec; 30(6):450-4. PubMed ID: 7008294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-class II antibody production prolongs renal allograft survival.
    Lewis RE; Brackin MN; Cruse JM; Brackin BT; Butkus D; Raju S; Crawford M; Krueger R; Kirchner K; Bower J
    Pathol Immunopathol Res; 1989; 8(5-6):287-99. PubMed ID: 2633201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful DR-incompatible cadaver kidney transplantation. Combined effect of HLA A and B matching and blood transfusion.
    Schulak JA; Goeken NE; Nghiem DD; Corry RJ
    Transplantation; 1984 Dec; 38(6):649-53. PubMed ID: 6390828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An apparent paradoxical effect of pretransplant blood transfusions. Its association with decreased anti-HLA antibody formation following unsuccessful renal transplantation.
    Lobo PI
    Transplantation; 1984 Jun; 37(6):562-4. PubMed ID: 6375015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful transplantation of 100 untransfused cyclosporine-treated primary recipients of cadaveric renal allografts.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplantation; 1988 Jan; 45(1):37-40. PubMed ID: 3276059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
    Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
    Transplantation; 1983 Oct; 36(4):384-7. PubMed ID: 6353705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HLA-DR matching between living kidney donors and recipients and of pretransplant blood transfusions on graft survival.
    Akiyama N; Sugimoto H; Kusaba R; Takahashi I; Ohsawa N; Inou T; Samaru Y
    Jpn J Exp Med; 1981 Feb; 51(1):37-43. PubMed ID: 6458714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLC compatibility, HLA-D and DR typing in cadaver kidney transplantations.
    Thomsen M; Morling N; Ladefoged J; Løkkegård H; Jakobsen B; Svejgaard A; Thaysen JH
    Scand J Urol Nephrol Suppl; 1980; 54():32-5. PubMed ID: 6452681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood transfusions and HLA compatibility in first cadaveric kidney transplants treated with cyclosporine A.
    Garcia LF; Arango AM; Henao JE; Arbelaez M
    Transplant Proc; 1988 Aug; 20(4):715-9. PubMed ID: 3043844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of mixed leukocyte culture using leukocytes from normal individuals, uremic patients, and allograft recipients.
    Agostino GJ; Kahan BD; Kerman RH
    Transplantation; 1982 Dec; 34(6):367-71. PubMed ID: 6218662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival.
    Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD
    Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
    Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Husberg B; Klintmalm G; Maurer W
    Lancet; 1986 Jul; 2(8498):66-9. PubMed ID: 2873380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of pretransplant transfusions and renal allograft survival.
    Sanfilippo F; Spees EK; Vaughn WK
    Transplantation; 1984 Apr; 37(4):344-50. PubMed ID: 6369662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts.
    Lagaaij EL; Hennemann IP; Ruigrok M; de Haan MW; Persijn GG; Termijtelen A; Hendricks GF; Weimar W; Claas FH; van Rood JJ
    N Engl J Med; 1989 Sep; 321(11):701-5. PubMed ID: 2671729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.